Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_36663
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 36663
Character Range: 1874951–1876035

36663                         Both:                                                                                                                                                                                                                                                                                                                                                                                                                                                                           687.75
                              (a) percutaneous placement of sacral nerve lead or leads using fluoroscopic guidance, or open placement of sacral nerve lead or leads; and
                              (b) intra‑operative test stimulation, to manage:
                              (i) detrusor over‑activity that has been refractory to at least 12 months conservative non‑surgical treatment; or
                              (ii) non‑obstructive urinary retention that has been refractory to at least 12 months conservative non‑surgical treatment
                              (Anaes.)